Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Sharon Freiman has experience in a broad range of corporate transactions, including debt and equity capital markets, bank financing and corporate restructuring. She also regularly advises clients on corporate governance issues, mergers and acquisitions and other general corporate matters.

Prior to joining Covington, Ms. Freiman was associated with another leading law firm in New York City.

  • Represented the underwriters in the initial public offering of Trevi Therapeutics, Inc., clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.
  • Represented the underwriters in a global offering of ordinary shares and ADSs of ERYTECH Pharma S.A., a France-based company developing therapies for rare forms of cancer and orphan diseases using a novel technology to encapsulate therapeutic drug substances inside red blood cells. 
  • Represented a leading international tequila company in its private offering of shares pursuant to Rule 144A and Regulation S and its concurrent initial public offering in Mexico.
  • Represented a media and entertainment conglomerate in various domestic and international debt offerings.
  • Represented a leading provider of wireless infrastructure:
    • in various debt and equity capital markets transactions; and
    • in its acquisition of a fiber services provider.
  • Represented a financial advisory and asset management firm in its registered debt offering and related redemption.
  • Represented the underwriters in the high-yield debt offering of a global provider of security products and solutions.
  • Represented the underwriters in the concurrent offering of common shares and mandatory convertible securities of a leading global automaker.
  • Represented a multinational telecommunications equipment company in connection with its unsecured revolving credit facility and term facility.
  • Represented leading investment banks in their capacities as arrangers of secured and unsecured credit facilities and dealer managers of equity tender offers.
  • Represented Credit Suisse as administrative agent and lender in connection with the bankruptcy of UCI International, LLC and certain of its affiliates.